Moderna faces $5 billion mRNA patent lawsuit after "Star Trek" ruling: Court denies Moderna's request for summary judgment, citing patent infringement over COVID-19 vaccine technology.

Moderna faces a $5 billion patent-infringement lawsuit over its COVID-19 vaccine technology, with the court ruling that the jury will decide whether the vaccine breached lipid nanoparticle technology patented by Genevant Sciences and Arbutus Biopharma. The trial centers on the vaccine's mRNA delivery mechanism, and Moderna's use of government immunity is limited by a federal judge. The case will now proceed to trial to determine patent validity and "literal infringement."